In this study, our purpose was to synthesize, prepare, and develop a BEZ235-loaded nanopreparation containing anti-GPC3 to target GPC3-positive HCC cells and achieve synergistic radiation therapy that would improve the killing of HCC. The gene discussed is GPC3; the disease is hepatocellular carcinoma.